Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haruko Kunitomi

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Oncotarget|October 27, 2017
Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancerYusuke Kobayashi, Hiroyasu Kashima, Yohan Suryo Rahmanto, et al.
Stem Cell Reports|May 3, 2024
H1FOO-DD promotes efficiency and uniformity in reprogramming to naive pluripotencyAkira Kunitomi, Ryoko Hirohata, Mitsujiro Osawa, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Oncotarget|October 27, 2017
Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancerYusuke Kobayashi, Hiroyasu Kashima, Yohan Suryo Rahmanto, et al.
Stem Cell Reports|May 3, 2024
H1FOO-DD promotes efficiency and uniformity in reprogramming to naive pluripotencyAkira Kunitomi, Ryoko Hirohata, Mitsujiro Osawa, et al.
Pageof 3